The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from the Leukemia and...
Vous n'êtes pas connecté
WEDNESDAY, Aug. 7, 2024 -- For pediatric patients with acute myeloid leukemia (AML), a pharmacogenomics-based 10 single nucleotide polymorphism cytarabine (Ara-C) score (ACS10) can be used to tailor induction regimens, yielding improved outcomes...
The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from the Leukemia and...
Urobiome research in children uncovers the unique microbial communities in their urinary tract, paving the way for improved pediatric health...
Empagliflozin, an SGLT2 inhibitor, is proven safe and effective for heart attack patients, offering a new treatment option to improve outcomes.
Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.
MONDAY, Sept. 16, 2024 -- For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of...
Artificial intelligence revolutionizes gene mutation prediction in lung cancer, offering more accurate, faster insights for personalized treatment...
Breakthrough in triple-negative breast cancer diagnosis: New test improves early detection, offering better outcomes and personalized treatment...
The World Health Organization evacuated 97 sick and critically injured patients from Gaza, half of them children.
MONDAY, Sept. 16, 2024 -- The risk for firearm reinjury among children who present with acute nonfatal firearm injury is 6 and 14 percent at one and...
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought,...